University College London Researchers Lead Trial to Test Remdesivir Drug on COVID-19 Patients
April 06, 2020
April 06, 2020
LONDON, England, April 6 -- The University College London issued the following news, dated April 2:
Patients with severe COVID-19 are being recruited to test the drug remdesivir as part of a new trial which is being led by the MRC Clinical Trials Unit at UCL. The trial is the first academic study of the drug as a treatment for coronavirus to take place in the UK.
The Adaptive COVID-19 Treatment Trial (ACTT-EU/UK) trial, which is taking place in about 75 hospitals global . . .
Patients with severe COVID-19 are being recruited to test the drug remdesivir as part of a new trial which is being led by the MRC Clinical Trials Unit at UCL. The trial is the first academic study of the drug as a treatment for coronavirus to take place in the UK.
The Adaptive COVID-19 Treatment Trial (ACTT-EU/UK) trial, which is taking place in about 75 hospitals global . . .